MOTT DAVID M
SEC insider (Form 3/4/5 filer). CIK 0001219871. Director at NOVAVAX INC (NVAX) and 2 other issuers. 36 reported Form 4/5 transactions since Sep 2024; latest on Jun 20, 2026. Located in WALTHAM, MA.
Companies MOTT DAVID M has filed insider reports for
- NOVAVAX INC (NVAX): Director
- ARDELYX, INC. (ARDX): Director
- Mersana Therapeutics, Inc. (MRSN): Director
MOTT DAVID M
CIK: 0001219871
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (36 total)
- Jun 20, 2026NVAX
NOVAVAX INC
ExerciseDirect18.9K shares- - Jun 18, 2026NVAX
NOVAVAX INC
AwardDirectRestricted Stock Units
14.2K shares- - Jun 18, 2026NVAX
NOVAVAX INC
AwardDirectStock Option (Right to Buy)
21.3K shares- - Jun 16, 2026ARDX
ARDELYX, INC.
AwardDirect26.5K shares- - Jun 16, 2026ARDX
ARDELYX, INC.
AwardDirect20.3K shares- - Feb 20, 2026ARDX
ARDELYX, INC.
PurchaseDirect333.3K shares at avg. $5.84$1.9M - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Tender OfferDirect23.5K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Tender OfferIndirect383 shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
788 shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
368 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 20, 2026 |  NVAX NOVAVAX INC | Exercise | 18,880 | - | $0 | Direct |
| Jun 18, 2026 | NVAX NOVAVAX INC | Award Restricted Stock Units | 14,180 | - | - | Direct |
| Jun 18, 2026 | NVAX NOVAVAX INC | Award Stock Option (Right to Buy) | 21,270 | - | - | Direct |
| Jun 16, 2026 |  ARDX ARDELYX, INC. | Award | 26,455 | - | $0 | Direct |
| Jun 16, 2026 | ARDX ARDELYX, INC. | Award | 20,282 | - | $0 | Direct |
| Feb 20, 2026 | ARDX ARDELYX, INC. | Purchase | 333,333 | $5.84 | $1,946,331 | Direct |
| Jan 6, 2026 |  MRSN Mersana Therapeutics, Inc. | Tender Offer | 23,546 | - | $0 | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Tender Offer | 383 | - | $0 | Indirect |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition Stock Option (right to buy) | 788 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition Stock Option (right to buy) | 368 | - | - | Direct |
1-10 of 36 transactions